Satoru Takahashi
Download the ICS Branding Pack
Podium Short Oral Session 19 Female Stress Urinary Incontinence 274 A phase 2, randomized, placebo-controlled, double-blind study of TAS-303 in female patients with stress urinary incontinence
ICS Member
Dr Satoru Takahashi declared on the Thursday 2nd February 2023 that they had the following existing or known future financial relationships or affiliations:
Scientific Committee Member